These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27785932)

  • 1. Elevated soluble CD14-subtype (PRESEPSIN; P-SEP) levels in rheumatoid arthritis (RA) patients with bacterial infection.
    Tsuji S; Kitatoube A; Kikuchi-Taura A; Oguro E; Shigesaka M; Okita Y; Shimizu T; Nii T; Teshigawara S; Tanaka E; Harada Y; Matsushita M; Hashimoto J; Ohshima S; Takahashi G; Endo S; Saeki Y
    Mod Rheumatol; 2017 Jul; 27(4):718-720. PubMed ID: 27785932
    [No Abstract]   [Full Text] [Related]  

  • 2. Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.
    Mussap M; Puxeddu E; Puddu M; Ottonello G; Coghe F; Comite P; Cibecchini F; Fanos V
    Clin Chim Acta; 2015 Dec; 451(Pt A):65-70. PubMed ID: 26232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders.
    Koh H; Aimoto M; Katayama T; Hashiba M; Sato A; Kuno M; Makuuchi Y; Takakuwa T; Okamura H; Hirose A; Nakamae M; Hino M; Nakamae H
    J Infect Chemother; 2016 Jul; 22(7):466-71. PubMed ID: 27184936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presepsin (sCD14-ST), an innate immune response marker in sepsis.
    Chenevier-Gobeaux C; Borderie D; Weiss N; Mallet-Coste T; Claessens YE
    Clin Chim Acta; 2015 Oct; 450():97-103. PubMed ID: 26164388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble CD14 and CD14 polymorphisms in rheumatoid arthritis.
    Mikuls TR; LeVan TD; Sayles H; Yu F; Caplan L; Cannon GW; Kerr GS; Reimold AM; Johnson DS; Thiele GM
    J Rheumatol; 2011 Dec; 38(12):2509-16. PubMed ID: 21921097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presepsin Levels of Patients with Crimean-Congo Hemorrhagic Fever.
    Demirpençe Ö; Doğan HO; Erşan S; Şahin M; Şahin H; Bakır M
    Jpn J Infect Dis; 2016 Nov; 69(6):505-509. PubMed ID: 27000451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST).
    Okamura Y; Yokoi H
    Clin Chim Acta; 2011 Nov; 412(23-24):2157-61. PubMed ID: 21839732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department.
    Romualdo LG; Torrella PE; González MV; Sánchez RJ; Holgado AH; Freire AO; Acebes SR; Otón MD
    Clin Biochem; 2014 May; 47(7-8):505-8. PubMed ID: 24560955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.
    Sargentini V; Ceccarelli G; D'Alessandro M; Collepardo D; Morelli A; D'Egidio A; Mariotti S; Nicoletti AM; Evangelista B; D'Ettorre G; Angeloni A; Venditti M; Bachetoni A
    Clin Chem Lab Med; 2015 Mar; 53(4):567-73. PubMed ID: 24897401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis.
    Kawanaka N; Yamamura M; Aita T; Morita Y; Okamoto A; Kawashima M; Iwahashi M; Ueno A; Ohmoto Y; Makino H
    Arthritis Rheum; 2002 Oct; 46(10):2578-86. PubMed ID: 12384915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department.
    Liu B; Yin Q; Chen YX; Zhao YZ; Li CS
    Respir Med; 2014 Aug; 108(8):1204-13. PubMed ID: 24931899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis.
    Cakır Madenci Ö; Yakupoğlu S; Benzonana N; Yücel N; Akbaba D; Orçun Kaptanağası A
    Burns; 2014 Jun; 40(4):664-9. PubMed ID: 24074718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.
    Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P
    World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges.
    Mussap M; Puxeddu E; Burrai P; Noto A; Cibecchini F; Testa M; Puddu M; Ottonello G; Dessì A; Irmesi R; Gassa ED; Fanni C; Fanos V
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):51-3. PubMed ID: 23025769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis by human monocytes is required for the secretion of presepsin.
    Arai Y; Mizugishi K; Nonomura K; Naitoh K; Takaori-Kondo A; Yamashita K
    J Infect Chemother; 2015 Aug; 21(8):564-9. PubMed ID: 26026662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study.
    Amoruso A; Sola D; Rossi L; Obeng JA; Fresu LG; Sainaghi PP; Pirisi M; Brunelleschi S
    Pharmacol Res; 2016 May; 107():308-314. PubMed ID: 27045818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of reference interval for presepsin, an early marker for sepsis.
    Giavarina D; Carta M
    Biochem Med (Zagreb); 2015; 25(1):64-8. PubMed ID: 25672468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased activation-induced cell death in peripheral lymphocytes of rheumatoid arthritis patients: the mechanism of action.
    Tang X; Yocum DE; Dejonghe D; Nordensson K; Lake DF; Richard J
    Immunology; 2004 Jul; 112(3):496-505. PubMed ID: 15196219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
    Takai C; Matsumoto I; Inoue A; Umeda N; Tanaka Y; Kurashima Y; Wada Y; Narita I; Sumida T
    Clin Exp Immunol; 2015 Jun; 180(3):458-66. PubMed ID: 25683200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.